Some visit links earn us a commission.

Medicare's Ozempic and Wegovy price in 2027: $274 for 30 days

By John Samaras, price analyst · Prices checked Nov 16, 2026

Read November 15, 2026 on cms.gov

From January 1, 2027, Medicare's negotiated price for Ozempic, Rybelsus and Wegovy is $274 for a 30-day supply. CMS puts the 2024 list price at $959, so the negotiated price is 71% lower. It is the price of the drug in Part D, not your copay.

What it costs without insurance

If Medicare won't cover it for weight loss

Who this affects

People with a standalone Part D plan or a Medicare Advantage drug plan who take Ozempic, Rybelsus or Wegovy for a use Part D covers, such as type 2 diabetes or cardiovascular disease. CMS counted 2,282,000 Part D enrollees who used these drugs in 2024. Part D still does not cover Wegovy for weight loss alone.

When it starts

CMS says the negotiated prices take effect on January 1, 2027.

If you lose coverage: cash now

Two cash programs to check.

No insurance needed.

Prices checked Nov 16, 2026.

  1. Eden$99 a monthIncludes medication, provider review and shippingcompounded semaglutidecompounded tirzepatide $129 a month
    Check price →Eden's GLP-1 page, then an online assessment
  2. Collective$59 a month, drug pricecompounded semaglutidecompounded tirzepatide $69 a month
    Check price →

What the CMS fact sheet says

Medicare prescription drug plans, including standalone Part D plans and Medicare Advantage-prescription drug plans, must include in their formularies the selected drugs
  • Per package, CMS lists $276.78 for one Ozempic 4 mg/3 mL pen, $276.78 for 30 Rybelsus 7 mg tablets and $385.63 for four Wegovy 2.4 mg pens.
  • Ozempic, Rybelsus and Wegovy are one selected drug in the program because all three are Novo Nordisk's semaglutide.
  • Every Medicare drug plan has to carry these drugs on its formulary from that date.
  • CMS says the price applies for as long as the drug stays in the negotiation program, with yearly inflation updates.

Sources:

What to do before January 1

  • Look up where Ozempic, Rybelsus or Wegovy sits on your 2027 plan's drug list. Coinsurance is a share of a price, so it can fall with the price.
  • For weight loss alone, check the Medicare GLP-1 Bridge instead.
  • If neither works, compare the cash routes on this page.

The Medicare GLP-1 Bridge in 2027. Medicare Advantage open enrollment for 2027. Novo's $675 list price from January 1.

What cash costs today

Compounded semaglutide and tirzepatide are pharmacy-made versions that are not Wegovy, Ozempic, Zepbound or Mounjaro.

Compounded prices are the monthly drug price at the lowest-priced program. Any membership is listed on that program's own page.

Buying cash in late November? GLP-1 Black Friday and Cyber Monday offers shows each program's 30-day low and high.

Frequently asked questions

Will I pay $274 for Ozempic on Medicare in 2027?
Not necessarily. $274 is the negotiated price for a 30-day supply. What you pay comes from your plan's own copay or coinsurance on that drug.
Does the negotiated price mean Medicare covers Wegovy for weight loss?
No. Part D covers Wegovy only for uses other than weight loss alone. For weight loss, the Medicare GLP-1 Bridge charges a $50 copay through December 31, 2027 for people who qualify.
How much lower is the Medicare price than the list price?
CMS puts the 2024 list price at $959 for 30 days and the negotiated price at $274, a 71% discount.

Cash does not go through your plan and does not count toward its deductible. Federal plan GLP-1 changes for 2027. GLP-1 coverage by payer.